SCHEMBL7713732

SCHEMBL7713732

Cc1cccc(C)c1N1[CH]CN(CC(O)CCCc2ccccc2Cl)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KCNH2 Q12809 1/20 0.38
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
USP2 O75604 1/20 0.36
DRD2 P14416 2/20 0.35
DRD3 P35462 2/20 0.35
ALDH1A1 P00352 4/20 0.35
GAA P10253 2/20 0.35
KDM4E B2RXH2 2/20 0.35
PRMT5 O14744 2/20 0.34
WDR77 Q9BQA1 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
P2RX7 Q99572 1/20 0.34
MAPK1 P28482 1/20 0.33
CXCR4 P61073 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705247 0.94 MEN1 (0.39) KMT2AMEN1LMNASMN1; SMN2KCNH2
SCHEMBL7705250 0.88 MEN1 (0.38) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL7711760 0.81 MEN1 (0.39) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL7713731 0.76 ABCB1 (0.42) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL7708649 0.75 SLC6A3 (0.45) KMT2AMEN1LMNASMN1; SMN2DRD2
SCHEMBL6284351 0.75 CYP3A4 (0.56) KMT2AMEN1LMNAKCNH2MAPT
SCHEMBL7711594 0.74 LMNA (0.47) KMT2AMEN1LMNASMN1; SMN2KCNH2
SCHEMBL7711567 0.74 CHRNA7 (0.44) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL7711797 0.73 MEN1 (0.48) KMT2AMEN1LMNASMN1; SMN2KCNH2
SCHEMBL7708651 0.71 CACNA1G (0.43) KMT2AMEN1LMNASMN1; SMN2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1259493-A2 SUBSTITUTED PIPERAZINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2002-11-27 EP claimed
WO-2001062744-A2 SUBSTITUTED PIPERAZINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2001-08-30 WO claimed
EP-1259493-A2 SUBSTITUTED PIPERAZINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2002-11-27 EP disclosed
WO-2001062744-A2 SUBSTITUTED PIPERAZINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2001-08-30 WO disclosed